Over at WHATNEXT partner site Patient Worthy, Rose Duesterwald reports that Dr. James Westin of the American Society of Clinical Oncology recently testified before the United States Congress about a nationwide shortage of certain cancer drugs in the U.S.
Duesterwald writes:
In his written statement directed to Congress, Dr. Westin added that he tells patients it is not a question of whether doctors know how to treat the cancer, but it is a question of whether or not they can get the drug. In many cases, the drug is simply not being manufactured.
The doctor went further by reiterating that this shortage of vital cancer drugs is a crisis, and that his patients and their families should be confident that they will get adequate care without further delays. Dr. Westin said that doctors should not be put in a position of making impossible choices.
You can read more about the congressional hearing on cancer drug shortages in the U.S. over at PatientWorthy.com.
Editor’s Note: Get Involved
Cancer doesn’t discriminate. Patient Worthy and its partners are interested in amplifying the voices of those from all identities and backgrounds. If you have a cancer journey to share, reach out here to learn more about how your voice can help spread awareness and inspire individuals from all walks of life.
Last modified: March 6, 2024